Therapies for Lennox-Gastaut syndrome

Therapies for Lennox-Gastaut syndrome

The treatment of Lennox-Gastaut Syndrome (LGS) has been improved with the introduction of the new anti-epileptic drugs: lamotrigine and topiramate, the employment of a ketogenic diet, and the availability of vagal nerve stimulation. It is difficult to provide recommendations for the treatment of LGS...

Full description

Bibliographic Details
Main Author:	Đurić Milena
Format:	Article
Language:	English
Published:	Serbian Medical Society 2005-01-01
Series:	Srpski Arhiv za Celokupno Lekarstvo
Subjects:	epileptic encephalopathy valproate lamotrigine topiramate felbamate
Online Access:	http://www.doiserbia.nb.rs/img/doi/0370-8179/2005/0370-81790506283D.pdf

Similar Items

Felbamate in Lennox-Gastaut Syndrome
by: J Gordon Millichap
Published: (1993-01-01)

EPIDEMIOLOGIC RESEARCH ON EPILEPSY IN MINSK
by: T. V. Dokukina, et al.
Published: (2015-03-01)

Topiramate in Lennox-Gastaut Syndrome
by: J Gordon Millichap
Published: (1999-07-01)

Generalized epilepsies: current conceptions and therapeutic approaches
by: L R Zenkov
Published: (2012-03-01)

Valproate-Induced Encephalopathy
by: J Gordon Millichap
Published: (2000-01-01)

Efficacy and Safety of Lamotrigine Adjunctive Therapy in Lennox-Gastaut Syndrome
by: Hui Jin Shin, et al.
Published: (2023-04-01)

Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update
by: Vivekanandan S, et al.
Published: (2010-01-01)

Dravet Syndrome as Adult Form of Epileptic Encephalopathy
by: J Gordon Millichap
Published: (2011-11-01)

Refining management strategies for Lennox–Gastaut syndrome: Updated algorithms and practical approaches
by: Stéphane Auvin, et al.
Published: (2025-02-01)

Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
by: Ostendorf AP, et al.
Published: (2017-04-01)

Quantifying the burden of disease in patients with Lennox Gastaut syndrome
by: Jochem K.H. Spoor, et al.
Published: (2021-01-01)

Cognitive effects of lamotrigine versus topiramate as adjunctive therapy in older adults with epilepsy
by: Steve S. Chung, et al.
Published: (2009-07-01)

Interrater reliability of interictal EEG waveforms in Lennox–Gastaut Syndrome
by: Derek K. Hu, et al.
Published: (2024-02-01)

The burden of illness in Lennox–Gastaut syndrome: a systematic literature review
by: Adam Strzelczyk, et al.
Published: (2023-03-01)

Does response to vagus nerve stimulation for drug‐resistant epilepsy differ in patients with and without Lennox–Gastaut syndrome?
by: Maxine Dibué, et al.
Published: (2023-08-01)

Topiramate-Induced Valproate Toxicity
by: J Gordon Millichap
Published: (2002-04-01)

Cognitive Effects of Topiramate and Valproate
by: J Gordon Millichap
Published: (2003-06-01)

Poisoning with the New Anticonvulsant Drugs: Clinical Findings and the Outcome
by: Nastaran Eizadi-Mood, et al.
Published: (2011-08-01)

Reiterating the role of corpus callosum in generalization of interictal and ictal epileptiform discharges: a case report with post-callosotomy intracranial electroencephalography in Lennox–Gastaut syndrome
by: S. Gopinath, et al.
Published: (2021-10-01)

A pilot study of topiramate in children with Lennox-Gastaut syndrome Estudo piloto com topiramato em crianças com síndrome de Lennox-Gastaut
by: MARILISA M. GUERREIRO, et al.
Published: (1999-06-01)

Changing Trends in Antiepileptic Drug Usage in Girls
by: J Gordon Millichap
Published: (2009-07-01)

Hormone Profiles with Valproate Monotherapy
by: J Gordon Millichap
Published: (2001-09-01)

Modern approaches in the treatment of Lennox–gastaut syndrome (a review of literature)
by: К. Yu. Мukhin, et al.
Published: (2018-11-01)

RUFINAMIDE IN THE TREATMENT OF LENNOX–GASTAUT SYNDROME: REVIEW OF FOREIGN LITERATURE
by: K. Yu. Mukhin, et al.
Published: (2015-06-01)

CLINICAL AND ENCEPHALOGRAPHIC CHANGES AT LENNOX–GASTAUT SYNDROME
by: K. Yu. Mukhin
Published: (2015-06-01)

Felbamate as an oral add-on therapy in six dogs with presumptive idiopathic epilepsy and generalized seizures resistant to drug therapy
by: Curtis Wells Dewey, et al.
Published: (2022-07-01)

Rufinamide (inovelon) in the treatment of Lennox–gastaut syndrome (a review of literature)
by: К. Yu. Мukhin, et al.
Published: (2018-11-01)

Experimental re-evaluation of flunarizine as add-on antiepileptic therapy
by: Anamika Thakur, et al.
Published: (2011-01-01)

The Use and Side Effect Profile of Valproate and Lamotrigine in Child and Adolescent Psychiatry
by: Yeşim SAĞLAM, et al.
Published: (2025-03-01)

Valproate/Lamotrigine and Growth Retardation
by: J Gordon Millichap
Published: (2001-12-01)

Lamotrigine (Lamictal) in Intractable Epilepsies
by: J Gordon Millichap
Published: (1997-06-01)

Lamotrigine-Associated Skin Rash
by: J Gordon Millichap
Published: (1999-08-01)

Prognosis of post-cardiac-arrest anoxic encephalopathy using felbamate: A case report
by: Hisanori Hasegawa, et al.
Published: (2017-01-01)

RUFINAMIDE (INOVELON) IN THE TREATMENT OF LENNOX–GASTAUT SYNDROME (A REVIEW OF LITERATURE AND CLINICAL CASE)
by: K. Yu. Mukhin, et al.
Published: (2016-01-01)

Non-invasive assessment of the effective dose of lamotrigine and topiramate for the treatment of epileptiform states in rats
by: R. G. Paronikyan, et al.
Published: (2019-07-01)

New antiepileptic drugs, cost-efficacy analysis
by: P. N. Vlasov, et al.
Published: (2014-01-01)

Fenfluramine for the treatment of status epilepticus: use in an adult with Lennox–Gastaut syndrome and literature review
by: Adam Strzelczyk, et al.
Published: (2024-02-01)

Seizures, behavioral deficits, and adverse drug responses in two new genetic mouse models of HCN1 epileptic encephalopathy
by: Andrea Merseburg, et al.
Published: (2022-08-01)

Comparison of the probability of four anticonvulsant mood stabilizers to facilitate polycystic ovary syndrome in women with epilepsies or bipolar disorder—A systematic review and meta-analysis
by: Jing Guo, et al.
Published: (2023-05-01)

A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector
by: Nicole Keuler, et al.
Published: (2022-06-01)